Who is sponsoring NCT05033860?

NCT05033860 is sponsored by Ningbo No. 1 Hospital.

What drugs are being tested in NCT05033860?

Interventions in NCT05033860: Read leaflets containing knowledge of COVID-19 and vaccination..

What condition does NCT05033860 study?

NCT05033860 studies Covid19, Knowledge, Attitudes, Practice.

Is NCT05033860 still recruiting?

NCT05033860 is currently status unknown. Last updated 5 September 2021.

Last reviewed 2021-09-05 · How we verify

NCT05033860

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents

Status unknown NA Last updated 5 September 2021

What this trial tests

NA trial testing Read leaflets containing knowledge of COVID-19 and vaccination. in Covid19 in 312 participants. Status unknown.

Timeline

18 August 2021

Primary endpoint
20 September 2021

20 September 2021

Quick facts

Lead sponsor	Ningbo No. 1 Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	prevention
Enrollment	312
Start date	18 August 2021
Primary completion	20 September 2021
Estimated completion	20 September 2021
Sites	1 location across China

Drugs / interventions tested

Read leaflets containing knowledge of COVID-19 and vaccination.

Conditions studied

Covid19 — all drugs for Covid19 →
Knowledge, Attitudes, Practice — all drugs for Knowledge, Attitudes, Practice →

Sponsor

Ningbo No. 1 Hospital

Who can join

18 and older, any sex, with Covid19 or Knowledge, Attitudes, Practice. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by a novel coronavirus, which has developed the global pandemic situation. The promotion of vaccination is an effective strategy to control the epidemic. A total of 19,5738,000 doses of COVID-19 vaccines have been reported in China until August 24th, 2021. During widespread vaccination, the education in COVID-19 prevention and vaccination for residents are also crucial. To figure out the influence of education during waiting time of vaccination, we have designed a randomized controlled trial and planned to distribute leaflets and questionnaires to the residents of Xidian (a town in Ninghai, Zhejiang). This study is of great significance for the prevention of COVID-19 pandemic.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Knowledge, Attitudes, and Practices toward COVID-19 and Vaccines among Chinese Small-Town Residents: A Cross-sectional Study.
Yu SY, Luo JJ, Cui HY, Shan KS, et al · · 2022 · cited 3× · PMID 35895333 · DOI 10.4269/ajtmh.22-0031
The Effect of Reading Leaflets During the Observation Period After Vaccination on Knowledge of COVID-19 and Vaccines Among Chinese Small Town Residents: A Randomized Controlled Trial.
Yu SY, Luo JJ, Shan KS, Xu L, et al · · 2022 · cited 1× · PMID 35400040 · DOI 10.3389/fpubh.2022.819446

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Ningbo No. 1 Hospital trials

Trials by the same sponsor.

NCT07181759 — Clinical Trial of VISOR vs fURS for Upper Urinary Tract Stone · NA · not yet recruiting
NCT07001865 — Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia · enrolling by invitation
NCT06984510 — Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population · recruiting
NCT06905795 — Screening and Intervention of MASLD in Children · NA · active not recruiting
NCT06987760 — Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05033860 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ningbo No. 1 Hospital
Last refreshed: 5 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05033860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing